c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease
- Sprache
-
Englisch
- Identifier
-
1195609493
Beteiligte Personen und Organisationen
Zheng, Kang
Cubero, Francisco Javier
Nevzorova, Yulia A.
Cubero, Francisco Javier
Nevzorova, Yulia A.
- DOI
-
10.18154/RWTH-CONV-221956
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:58 MEZ
Beteiligte
- Zheng, Kang
- Cubero, Francisco Javier
- Nevzorova, Yulia A.
Ähnliche Objekte (12)
Fibrotic Events in the Progression of Cholestatic Liver Disease
Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease
An Experimental DUAL Model of Advanced Liver Damage
Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice
Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2) : A Retrospective Single-Center Study from Spain
Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease
Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death?
Hepatic Tissue Environment in NEMO-Deficient Mice Critically Regulates Positive Selection of Donor Cells after Hepatocyte Transplantation
Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy
Pharmacological Inhibition of Cyclin-Dependent Kinases Triggers Anti-Fibrotic Effects in Hepatic Stellate Cells In Vitro
Fat : Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)
Fibrotic Events in the Progression of Cholestatic Liver Disease
Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease
An Experimental DUAL Model of Advanced Liver Damage
Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice
Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2) : A Retrospective Single-Center Study from Spain
Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease
Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death?
Hepatic Tissue Environment in NEMO-Deficient Mice Critically Regulates Positive Selection of Donor Cells after Hepatocyte Transplantation
Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy
Pharmacological Inhibition of Cyclin-Dependent Kinases Triggers Anti-Fibrotic Effects in Hepatic Stellate Cells In Vitro
Fat : Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)
Fibrotic Events in the Progression of Cholestatic Liver Disease
Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease
An Experimental DUAL Model of Advanced Liver Damage
Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice
Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2) : A Retrospective Single-Center Study from Spain
Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease
Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death?
Hepatic Tissue Environment in NEMO-Deficient Mice Critically Regulates Positive Selection of Donor Cells after Hepatocyte Transplantation
Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy
Pharmacological Inhibition of Cyclin-Dependent Kinases Triggers Anti-Fibrotic Effects in Hepatic Stellate Cells In Vitro